AI assistant
AstraZeneca Pharma India Ltd. — Board/Management Information 2023
Sep 15, 2023
60656_rns_2023-09-15_915e4eb9-093e-4cbf-a96b-854ce9c4afe8.pdf
Board/Management Information
Open in viewerOpens in your device viewer
==> picture [452 x 78] intentionally omitted <==
September 15, 2023
The Manager- Listing BSE Limited
Corporate Relationship Dept., 5[th] Floor, New Trading Ring Rotunda Building, P J Towers, Dalal Street, Fort, Mumbai – 400 001
The Manager- Listing National Stock Exchange of India Limited Exchange Plaza, 5[th] Floor, Plot No. C/1, G - Block Bandra –Kurla Complex, Bandra (E), Mumbai – 400 051
Dear Sir(s),
Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure - Requirements) Regulations, 2015 Appointment of Senior Management Personnel
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company has approved the appointment of Mr. Praveen Akkinepally as the Business Unit Head – Oncology with effect from November 1, 2023. Mr. Praveen will be part of the Senior Management team of the Company.
In this regard, please find the details as required under the SEBI Circular SEBI/HO/CFD/CFDPoD-1/P/CIR/2023/123 dated July 13, 2023 attached herewith as Annexure – A .
Kindly take the above information on record.
For AstraZeneca Pharma India Limited
MANAS Digitally signed by MANASA RAMA A RAMA Date: 2023.09.15 10:12:52 +05'30'
Manasa. R Company Secretary
==> picture [453 x 64] intentionally omitted <==
==> picture [452 x 78] intentionally omitted <==
Annexure - A
Appointment of Mr. Praveen Akkinepally as Business Unit Head - Oncology
| Sl. No | Particulars | Details |
|---|---|---|
| 1 | Reason for change viz. appointment, resignation, removal, death or otherwise; |
Appointment of Mr. Praveen Akkinepally as Business Unit Head - Oncology. |
| 2 | Date of appointment and term of appointment |
Effective November 1, 2023 Term of appointment – Full – time employement |
| 3 | Brief Profile | Mr. Praveen Akkinepally holds an MBA from The University of Michigan, Ross School of Business and an Master in Public Health from Johns Hopkins University, Bloomberg School of Public Health. He has been recognized by Diversity MBA Magazine in their annual Top 100 Under 50 list of Executive and Emerging Leaders. Currently, Mr. Praveen Akkinepally is the Head of Lung Cancer Commercialization, AstraZeneca Gaithersburg, MD, USA. |
| 4 | Disclosure of relationships between directors |
Not Applicable |
==> picture [453 x 64] intentionally omitted <==